Get the Stockscreener App
9.25
1.91%
-0.18
After Hours:
3.43
-5.82
-62.92%
Mimedx Group Inc stock is traded at $9.25, with a volume of 510.77K.
It is down -1.91% in the last 24 hours and up +59.21% over the past month.
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
See More
Previous Close:
$9.43
Open:
$9.43
24h Volume:
510.77K
Relative Volume:
0.72
Market Cap:
$1.36B
Revenue:
$340.46M
Net Income/Loss:
$98.11M
P/E Ratio:
-52.98
EPS:
-0.1746
Net Cash Flow:
$43.17M
1W Performance:
+0.54%
1M Performance:
+59.21%
6M Performance:
+29.37%
1Y Performance:
+18.89%
1-Day Range:
$9.055
$9.44
1-Week Range:
$8.99
$9.64
52-Week Range:
$5.47
$9.64
Mimedx Group Inc Stock (MDXG) Company Profile
Name
Mimedx Group Inc
Sector
Industry
Phone
(770) 651-9100
Address
1775 W OAK COMMONS COURT, NE, MARIETTA
Compare MDXG with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| 6.49 | 0 | 0 | 0 | 0 | 0.00 | |
GOODO
Gladstone Commercial Corporation
|
21.57 | 372.90M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.1451 | 306.21M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
MOBBW
Mobilicom Limited Warrants
|
0.248 | 278.60M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
2.30 | 99.04M | 0 | 0 | 0 | 0.00 |
|
JUNE
Dhandho Junoon Etf
|
4.50 | 58.53M | 0 | 0 | 0 | 0.00 |
Mimedx Group Inc Stock (MDXG) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-02-24 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-07-24 | Initiated | Lake Street | Buy |
| Oct-27-23 | Initiated | Craig Hallum | Buy |
| Oct-13-22 | Initiated | Mizuho | Buy |
| Jul-26-21 | Initiated | Northland Capital | Outperform |
| Mar-19-21 | Initiated | H.C. Wainwright | Buy |
View All
Mimedx Group Inc Stock (MDXG) Latest News
MiMedx Group Q3 2024 Earnings Preview - MSN
Isthmus Partners LLC Trims Holdings in MiMedx Group, Inc. (NASDAQ:MDXG) - MarketBeat
MiMedx Group Stock Soars to 52-Week High of $9.62 By Investing.com - Investing.com South Africa
MiMedx Group Stock Soars to 52-Week High of $9.62 - Investing.com India
MDXG (MiMedx Group) 3-Year Book Growth Rate : 0.00% (As of Sep. 2024) - GuruFocus.com
MDXG (MiMedx Group) Net Income From Continuing Operations : $85.8 Mil (TTM As of Sep. 2024) - GuruFocus.com
Chronic Wound Care Market to Expand at a Modest 4.17% CAGR through 2031 | SkyQuest Technology - Benzinga
MDXG (MiMedx Group) 3-Year Revenue Growth Rate : -1.30% (As of Sep. 2024) - GuruFocus.com
(MDXG) Investment Report - Stock Traders Daily
MDXG (MiMedx Group) Total Liabilities : $62.9 Mil (As of Sep. 2024) - GuruFocus.com
MiMedx Group (NASDAQ:MDXG) Reaches New 1-Year HighHere's Why - MarketBeat
Mizuho increases MiMedx stock target, rating held on Medicare decision - Investing.com
Mizuho increases MiMedx stock target, rating held on Medicare decision By Investing.com - Investing.com Canada
MiMedx stock soars to 52-week high, touches $9.28 - Investing.com India
MiMedx stock soars to 52-week high, touches $9.28 By Investing.com - Investing.com Canada
MiMedx Group (NASDAQ:MDXG) Shares Gap UpShould You Buy? - MarketBeat
MIMEDX’s Advocacy to Rein in Runaway Medicare Spend for - GlobeNewswire
MIMEDX Products Secure Medicare Coverage as 200+ Competitors Cut from 2025 LCD Update | MDXG Stock News - StockTitan
(MDXG) Trading Advice - Stock Traders Daily
Analysts Set MiMedx Group, Inc. (NASDAQ:MDXG) Price Target at $12.00 - MarketBeat
MiMedx Group (NASDAQ:MDXG) Downgraded to Buy Rating by StockNews.com - MarketBeat
Trigran Investments, Inc. Expands Stake in MiMedx Group Inc - GuruFocus.com
MiMedx Group's (NASDAQ:MDXG) Promising Earnings May Rest On Soft Foundations - Yahoo Finance
There's No Escaping MiMedx Group, Inc.'s (NASDAQ:MDXG) Muted Earnings Despite A 27% Share Price Rise - Simply Wall St
MIMEDX Group's SWOT analysis: wound care firm's stock faces market headwinds - Investing.com
Vanguard Group Inc's Strategic Acquisition in MiMedx Group Inc - GuruFocus.com
MIMEDX to Participate in Upcoming Investor Conferences - GlobeNewswire
MiMedx Group, Inc. (NASDAQ:MDXG) Shares Acquired by Harbor Capital Advisors Inc. - MarketBeat
Northland Capmk Expects Increased Earnings for MiMedx Group - MarketBeat
MiMedx Group Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
MiMedx Group, Inc. (NASDAQ:MDXG) Q3 2024 Earnings Call Transcript - Insider Monkey
Possible Signal As MiMedx Group Insiders Sell US$659k In Stock - Simply Wall St
Earnings call: MiMedx reports growth and optimism amidst challenges - Investing.com
Earnings call: MiMedx reports growth and optimism amidst challenges By Investing.com - Investing.com UK
MiMedx Group Inc (MDXG) Q3 2024 Earnings Call Highlights: Strong - GuruFocus.com
MiMedx: Q3 Earnings Snapshot - Milford Mirror
MiMedx Group Inc (MDXG) Q3 2024 Earnings Call Highlights: Strong International Growth and New ... - Yahoo Finance
MiMedx Group Inc. Reports Q3 2024 Financial Results - TipRanks
MiMedx Group Reports 3% Sales Increase in Q3 2024 - TipRanks
MiMedx (MDXG) Q3 Earnings and Revenues Surpass Estimates - Yahoo Finance
MIMEDX Announces Third Quarter 2024 Operating and Financial Results - The Manila Times
MiMedx Group, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
MiMedx Group (MDXG) to Release Quarterly Earnings on Wednesday - MarketBeat
(MDXG) Trading Signals - Stock Traders Daily
MiMedx Group, Inc. (NASDAQ:MDXG) Receives Consensus Rating of "Buy" from Brokerages - MarketBeat
MiMedx Group (NASDAQ:MDXG) Lowered to "Buy" at StockNews.com - MarketBeat
MiMedx Group, Inc. (NASDAQ:MDXG) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap? - Yahoo Finance
MIMEDX to Host Third Quarter 2024 Operating and Financial Results Conference Call on October 30 - GlobeNewswire
Mimedx Group Inc Stock (MDXG) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.61%
1.14%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):